145 related articles for article (PubMed ID: 11568777)
1. Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: a 2-year randomized, placebo-controlled, comparative study.
Post MS; van der Mooren MJ; van Baal WM; Neele SJ; Netelenbos JC; Kenemans P
Am J Obstet Gynecol; 2001 Sep; 185(3):557-62. PubMed ID: 11568777
[TBL] [Abstract][Full Text] [Related]
2. Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study.
de Azevedo GD; do Prado MF; Ferriani RA; dos Reis RM; Berezowski AT; Ribeiro TF; Silva E; de Oliveira Maranhão TM; Silva de Sá MF
Maturitas; 2004 Mar; 47(3):195-200. PubMed ID: 15036489
[TBL] [Abstract][Full Text] [Related]
3. A randomised, double-blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life.
Voss S; Quail D; Dawson A; Bäckström T; Aguas F; Erenus M; The HS; Bonnar J; De Geyter C; Hunter M; Nickelsen T;
BJOG; 2002 Aug; 109(8):874-85. PubMed ID: 12197366
[TBL] [Abstract][Full Text] [Related]
4. A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine.
Smolders RG; Vogelvang TE; Mijatovic V; van Baal WM; Neele SJ; Netelenbos JC; Kenemans P; van der Mooren MJ
Maturitas; 2002 Feb; 41(2):105-14. PubMed ID: 11836041
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
[TBL] [Abstract][Full Text] [Related]
6. Transvaginal color Doppler sonographic evaluation of the uterus in postmenopausal women on daily raloxifene therapy.
Chittacharoen A; Theppisai U; Manonai J
Climacteric; 2002 Jun; 5(2):156-9. PubMed ID: 12051111
[TBL] [Abstract][Full Text] [Related]
7. The effect of raloxifene and tibolone on the uterine blood flow and endometrial thickness: a transvaginal Doppler study.
Botsis D; Christodoulakos G; Papagianni V; Lambrinoudaki I; Aravantinos L; Makrakis E; Creatsas G
Maturitas; 2006 Feb; 53(3):362-8. PubMed ID: 16159701
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.
Johnston CC; Bjarnason NH; Cohen FJ; Shah A; Lindsay R; Mitlak BH; Huster W; Draper MW; Harper KD; Heath H; Gennari C; Christiansen C; Arnaud CD; Delmas PD
Arch Intern Med; 2000 Dec 11-25; 160(22):3444-50. PubMed ID: 11112238
[TBL] [Abstract][Full Text] [Related]
10. Effects of the selective estrogen receptor modulator, raloxifene, on carotid artery pulsatility index in postmenopausal women.
Setacci C; la Marca A; Agricola E; Morgante G; Setacci F; Cappelli A; Petraglia F; De Leo V
Am J Obstet Gynecol; 2002 Apr; 186(4):832-5. PubMed ID: 11967516
[TBL] [Abstract][Full Text] [Related]
11. Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women.
Giltay EJ; Duschek EJ; Katan MB; Zock PL; Neele SJ; Netelenbos JC
J Endocrinol; 2004 Sep; 182(3):399-408. PubMed ID: 15350182
[TBL] [Abstract][Full Text] [Related]
12. Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women.
van Baal WM; Kenemans P; Stehouwer CD; Peters-Muller ER; van Vugt JM; van der Mooren MJ
Am J Obstet Gynecol; 1999 Dec; 181(6):1365-73. PubMed ID: 10601914
[TBL] [Abstract][Full Text] [Related]
13. Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.
Usall J; Huerta-Ramos E; Labad J; Cobo J; Núñez C; Creus M; Parés GG; Cuadras D; Franco J; Miquel E; Reyes JC; Roca M;
Schizophr Bull; 2016 Mar; 42(2):309-17. PubMed ID: 26591005
[TBL] [Abstract][Full Text] [Related]
14. Carotid artery intima-media thickness after raloxifene treatment.
Mack WJ; Dhungana B; Dowsett SA; Keech CA; Feng M; Li Y; Hodis HN
J Womens Health (Larchmt); 2007 Apr; 16(3):370-8. PubMed ID: 17439382
[TBL] [Abstract][Full Text] [Related]
15. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
[TBL] [Abstract][Full Text] [Related]
16. Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women.
Vogelvang TE; Leurs JR; van der Mooren MJ; Mijatovic V; Hendriks DF; Neele SJ; Netelenbos JC; Kenemans P
Menopause; 2004; 11(1):110-5. PubMed ID: 14716191
[TBL] [Abstract][Full Text] [Related]
17. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
Hernández E; Valera R; Alonzo E; Bajares-Lilue M; Carlini R; Capriles F; Martinis R; Bellorin-Font E; Weisinger JR
Kidney Int; 2003 Jun; 63(6):2269-74. PubMed ID: 12753317
[TBL] [Abstract][Full Text] [Related]
18. Transition from estrogen therapy to raloxifene in postmenopausal women: effects on treatment satisfaction and the endometrium-a pilot study.
Davis SR; O'Neill SM; Eden J; Baber R; Ekangaki A; Stocks JM; Thiebaud D
Menopause; 2004; 11(2):167-75. PubMed ID: 15021446
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with vaginal estradiol tablets--an impact on uterine artery blood flow.
Dmitrovic R; Klobucar A; Bauman R; Cvitkovic-Kuzmic A; Skalko D; Sonicki Z
Maturitas; 2005 Apr; 50(4):300-4. PubMed ID: 15780530
[TBL] [Abstract][Full Text] [Related]
20. Mood effect of raloxifene in postmenopausal women.
Jarkova NB; Martenyi F; Masanauskaite D; Walls EL; Smetnik VP; Pavo I
Maturitas; 2002 May; 42(1):71-5. PubMed ID: 12020982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
